Daphne Koller is an AI pioneer, MacArthur fellow, member of the National Academy of sciences and the founder and CEO of drug discovery and development company insitro. She’ll talk about how attitudes surrounding AI have evolved in her multi-decade career and what's ahead - including how technology is reshaping drug discovery, paving the way for more targeted treatments for the patients who can benefit most. But maximizing AI-powered innovation will depend on better investments in data aggregation, quality and collection and navigating hype cycles that can distract from real impact.
This academic-turned-entrepreneur will also share how founding insitro (and a previous company, Coursera) helped her expand her leadership and management skills, all while driving home the importance of shaping a company culture. At insitro, this focus building a culture that works for unique needs led to a special ‘helix’ inspired-structure that helps discovery biologists, automation engineers and others in the company's cross-functional teams keep communication flowing, problem solve, and prevent the siloes that can hold true innovation back.
Podden och tillhörande omslagsbild på den här sidan tillhör World Economic Forum / Linda Lacina. Innehållet i podden är skapat av World Economic Forum / Linda Lacina och inte av, eller tillsammans med, Poddtoppen.
